India has suspended a drugmaker's manufacturing licence after the...
Category:
Health
Latest
Govt working on mission mode to address mental health as a public health concern: MoS
Bharti Pravin Pawar,minister of state, Ministry of Health &...
Ceiling prices of 691 formulations have been fixed under NELM 2022: Centre
Replying to a query regarding the Pradhan Mantri Bhartiya...
Bharat Biotech’s COVID-19 shot 81% effective,Modi’s ministers choose it over AstraZeneca
Many state officials and doctors have refused to take COVAXIN before its effectiveness could be proved. Bharat Biotech says it has completed the late-stage trial and results will be out this month.
“COVAXIN demonstrates high clinical efficacy trend against COVID-19 but also significant immunogenicity against the rapidly emerging variants,” Bharat Biotech Chairman Krishna Ella said in a statement, referring to its vaccine.
Doctor appears in court video call while performing surgery
The judge said he didn’t think it was appropriate to conduct trial under the circumstances. He told Green he’d rather set a new date for trial “when you’re not actively involved or participating and attending to the needs of a patient.”
UK business interruption insurance anguish far from over
The Financial Conduct Authority (FCA) said the case could affect 370,000 policyholders and 60 insurers, with the potential for billions of pounds in claims.
Many small businesses had policies that enabled them to claim a maximum of 50,000-100,000 pounds for disruption caused by the pandemic and subsequent lockdowns.
India’s present overall case positivity rate suggests COVID-19 close to being under control
Addressing a weekly press conference, Union Health Secretary Rajesh Bhushan said though certain states, including Maharashtra, Kerala, Tamil Nadu, Punjab, Gujarat and Madhya Pradesh, are seeing a surge in number of COVID-19 active cases, ”the fact remains that recovered cases are still more than 97 per cent and India’s total active cases are less than 2 per cent (1.51 per cent)”. Bhushan said that central teams have been deputed to Maharashtra, Tamil Nadu, Punjab, Gujarat and Madhya Pradesh.
COVID times: Airlines industry awaits guidelines for vaccinated passengers
IATA Regional Director for Airports and External Relations (Asia Pacific) Vinoop Goel said regulations and restrictions related to travel are determined by governments, adding that it hopes that the governments will consider relaxing travel restrictions for vaccinated persons.
Less than 10 pc of world’s population have coronavirus antibodies: WHO Chief scientist
The only way to achieve mass herd immunity is through vaccination, the WHO chief scientist stressed.
According to Swaminathan, the currently approved vaccines offer good protection against severe disease, hospitalization and death from COVID-19. The vaccines’ effectiveness with regard to mild disease and asymptomatic coronavirus infection is still being studied.
Machine learning could aid mental health diagnoses: Study
Patients with depression or psychosis rarely experience symptoms of purely one or the other illness. Historically, this has meant that mental health clinicians give a diagnosis of a ‘primary’ illness, but with secondary symptoms. Making an accurate diagnosis is a big challenge for clinicians and diagnoses often do not accurately reflect the complexity of individual experience or indeed neurobiology.
Insurers have to provide some key info to their health customers twice a year:IRDAI
Among the key information, insurers have to provide to their health insurance customers by 1st June 2021 are-,
-Extent of coverage available by way of available Sum Insured and Cumulative Bonus,
-Number of insured people covered under policy,
– Policy period,
-Number and amount of claim settled (under relevant period), if any,
-Balance Sum Insured and Accrued cumulative bonus available, if any,
-Due date of renewal and premium payment frequency,
– Premium amount due on renewal (to be specified at the time of renewal)
India reports 15,510 new COVID-19 cases, 106 deaths
Prime Minister Narendra Modi on Monday took the first dose of Covaxin, India’s homegrown coronavirus vaccine developed by biotechnology firm Bharat Biotech and the Indian Council of Medical Research, addressing hesitancy over the COVID-19 vaccine.
U.S. authorizes Johnson & Johnson’s COVID-19 vaccine
The single-shot vaccine is highly effective in preventing severe Covid-19, including against newer variants, the Food and Drug Administration (FDA) said before giving it a green light.